Antaros Medical presents First-in-class PET tracer for the glucagon receptor at EASD 2017

Lisbon, 12 September

Antaros Medical, in collaboration with Sanofi, presents important data at the 53rd Annual Meeting of the European Association for the study of diabetes (EASD) on a first-in-class Glucagon (GCG) Positron Emission Tomography (PET) ligand, with suitable properties for clinical development targeting the glucagon receptor.

In addition, Antaros founders contribute to science at EASD 2017 in three additional poster: